Howdy, Stranger!

It looks like you're new here. If you want to get involved, click one of these buttons!

Here's a statement of the obvious: The opinions expressed here are those of the participants, not those of the Mutual Fund Observer. We cannot vouch for the accuracy or appropriateness of any of it, though we do encourage civility and good humor.
  • Grandeur Peak Global Micro Cap Fund subscription offering info
    @Mulder420 After hearing two different stories from two different people at GP, I emailed in my form sans adviser code (just left that whole section blank). I received a confirmation email. We'll see what happens...I've got no interest in opening another account at GP...especially if they only allot me $1000 or so, depending on total subscription. David gave some other options to check out, as well.
  • Sequoia Fund Suffers Big Loss?
    With Valeant, you basically have people saying on one hand that it is the next Berkshire Hathaway and on the other hand, you have Berkshire Hathaway being very negative on it (Munger has been very negative - “Valeant is like ITT and Harold Geneen come back to life, only the guy is worse this time.” http://www.fool.ca/2015/04/02/why-is-warren-buffetts-right-hand-man-so-bearish-on-valeant-pharmaceuticals-intl-inc/) This is a longer discussion by Sequoia on Valeant - http://www.valuewalk.com/2015/08/valeant-pharma-sequoia/
    My issue really becomes the idea that the Valeant business model is the perfect target for politicians. It does little in the way of R & D and basically snaps up drugs/treatments/companies and raises prices. Some people have problems with "platform companies", but Danaher (DHR) has been successful for decades. When you apply that business model to the healthcare industry it's just ripe for controversy.
    And maybe nothing happens with the subpoena that Valeant got yesterday, but I think the controversy and debate over that company is not likely over.
    Also, for a company of Valeant's size, it's an unbelievably volatile stock.
  • Active Share Food Fight
    Jack Vogel, at Alpha Architect, updates (with all links needed to follow) the recent back-and-forth between the authors of the original papers describing the active share effect and the contrarians at AQR who don't think much of it.
    http://blog.alphaarchitect.com/2015/09/21/active-share-debate-aqr-versus-academics/
    The authors have not taken kindly to AQR's questioning of their claims, and write in the abstract of a swing-back paper:
    This paper’s first and main aim is to establish that the AQR paper should not be interpreted using typical academic standards. Instead, our conjecture is that this AQR paper falls into a wonderfully creative but altogether different genre, which we label the Wonderland Genre, as its main characteristic seems to be “Sentence First, Verdict Later.” ...{...] Thirdly and finally, we impolitely consider why AQR may not be a big fan of Active Share by taking a look at the AQR mutual funds offered to retail investors. We find that these tend to have relatively low Active Shares, have shown little outperformance to date (with performance data ending in 2014) and thus seem fairly expensive given the amount of differentiation they offer.
    h/t Tadas Viskanta @ Abnormal Returns
  • Sequoia Fund Suffers Big Loss?
    Yes, SEQUX does have 29% of its portfolio in Valeant. However, look at the great (relative to the market) YTD performance of SEQUX, which probably is mainly due to Valeant. And look at Valeant's great YTD performance of +33%.
    I wouldn't say that SEQUX "lost" $1.2B on Valeant. They have probably gained a lot on Valeant since purchase, although I don't have the purchase date. Gained a lot, then gave back some in the past week, month, 3 months.
    The "loss" in the past week and past month is a paper loss only. I seriously doubt that SEQUX has sold the position while it has been down......
    Cheers,
  • Sequoia Fund Suffers Big Loss?
    According to Bloomberg, The Sequoia Fund lost $1.2 billion on its investment in Valeant. That’s a big loss for the 7.8 billion Sequoia. Bloomberg says that Valeant represented 29 percent of the fund’s holdings. That’s an unbelievably big bet for a fund that’s so highly respected. Is this accurate? [If so, this fund's Great Owl Fund status should be revoked.]
    http://www.bloomberg.com/news/articles/2015-09-28/sequoia-fund-managers-suffer-1-2-billion-loss-as-valeant-falls?module=TopNews&position=4_reaction
  • 2015 YE Mutual Fund Distributions
    The user and all related content has been deleted.
  • Domestic Large Cap Value Fund - BPAVX, JVAAX, TWEIX, BRLVX?
    Thanks. That's very helpful. It looks like this is a pure quant fund (albeit with multiple models).
    It's curious that this information is not in any SEC filings. The only similar information (in the prospectus) is that Harindra de Silva, Ph.D, a member of the Analytic Investors, LLC management team "works primarily on research for the strategy (i.e., model maintenance and design)". From "model" one might infer quant management for this sleeve.
    The only source I can find for the information you provided are "Fact Sheets" for the fund, such as this one dated June 30, 2015. Stranger still is that these are not published by SEI, in the sense that there doesn't seem to be a way to navigate to them.
    FWIW, here's their glossy on their Managed Volatility funds.
    All in all, a bit unusual, like they don't want you to know about the fund. Or, it's all in plain sight and I'm just having a bad day :-)
  • High yield corp bonds getting killed today
    @PRESSmUP Holdings in the chart are as of March 31, 2015. There may have been a few changes since then.
    @Dex Maybe this is a good thing? [of course, junk declines often foreshadow broader mkt corrections, so when I suggest "good" you're probably thinking "whatchoo talkin' 'bout, Willis?"] :)
  • Domestic Large Cap Value Fund - BPAVX, JVAAX, TWEIX, BRLVX?
    "It's a little hard to get a handle on its management - three different management companies, each with several managers involved. Don't know whether each team is allocated a sleeve, or if there is dynamic allocation among teams."
    Managers - Start Date - Attributes - Allocation
    1. AJO, L.P. - Oct 29, 2004 - Proprietary, multi-factor quantitative model seeks mispriced securities - 27%
    2. Analytic Investors LLC - Oct 29, 2004 - Disciplined quantitative methods - 39%
    3. LSV Asset Management - Dec 16, 2010 - Strong, deep value-oriented quantitative model - 34%
     Investment Philosophy and Process
    The Fund uses a multi-manager approach to portfolio construction that seeks to generate excess returns (i.e., returns in excess of benchmark) and at the same time provide diversification by avoiding over- concentration in a single investment style, sector or market trend. Our analysis seeks to identify each manager's competitive advantage and characteristics of that advantage that can be monitored on an ongoing basis. Asset allocation to a given manager is based on the manager's skill set, the current macro economic environment, and the risks inherent in each manager's strategy.
  • Domestic Large Cap Value Fund - BPAVX, JVAAX, TWEIX, BRLVX?
    Looks like SVOAX lines up very well with BPAIX (the shareclass of BPVAX with the same min). It's doing 3-6% better short term (YTD, 1 year), a bit less than 1% worse over 3 and 10 year spans, 1.25% better over 5 years.
    Clearly doing better tha BPAIX in the 2015 down market, and held up nearly as well as BPAIX in 2008 (losing about 2% more, but still about 10% less than the market).
    It did that as a midcap blend fund, and has been gradually drifting over to large, then value where it sits now. It's a minimum volatility fund (check its name); its low standard deviation and M* risk attest to that. On the other hand, that also means it is subject to higher turnover as noted in its prospectus: "Due to its investment strategy, the Fund may buy and sell securities frequently."
    Overall, looks like an interesting fund, definitely worth consideration.
    It's a little hard to get a handle on its management - three different management companies, each with several managers involved. Don't know whether each team is allocated a sleeve, or if there is dynamic allocation among teams.
    SEI apparently has two different sets of funds with the same names, organized as series of SEI Institutional Managed Trust (including SVOAX), and as series of SEI Institutional Investment Trusts. There you'll find another SEI US US Managed Volatility Fund (SVYAX), managed with nearly the identical slew of managers, lower expenses and a similar but slightly better record (some of which may be attributable to a lower ER). Unfortunately, this appears to be a "true" institutional fund, sold only to institutions, 401k plans, etc.
  • Transfer from one fund to other - DCA or lumpsum?
    #3 doesn't make sense to me. Anytime you move to cash you're gambling. Markets can move in either direction over the short term. I wouldn't want to risk the potential downside should markets rise dramatically while I'm sitting in cash. (This assumes your current allocation is the correct one for you, which I understand to be the case.)
    The 1st and 2nd options appear to be a question of whether to move the money all at once or in stages. That depends in part on how unhappy you are with the current fund/fiduciary and possibly on any fees and penalties you might incur from the move. But, in most cases like this, I would move the money in stages (three or four chunks spaced several weeks or even months apart). That's because even very similar funds can move in different directions over shorter periods. Moving the money in stages tends to minimize the impact of such short term fluctuations.
  • Are foreign dividend-paying funds under-reporting expense ratios for retirement account investors?

    Think that this sort of information should be disclosed by the funds for benefit of shareholders that don't have the time or resources to gather the information and calculate the numbers themselves.
    I'm 100% with you here. It seems like you are starting with this and backing into "solutions" that make no sense, in part because you're tying ERs (and other SEC disclosures) to taxes when those are two different (though related) things, calculated in ways that don't always line up.
    There are other costs not included in the ER, like trading costs. See WSJ, "The Hidden Cost of Mutual Funds". I think all this information should be readily accessible.
    That applies to all funds, not just funds that pass through the foreign taxes paid. Just because a fund has only 30% of its assets in foreign countries, like VGENX, doesn't mean that the fund isn't paying foreign taxes, or that your net returns aren't getting correspondingly reduced.
  • Are foreign dividend-paying funds under-reporting expense ratios for retirement account investors?
    Your original question was: "Why then, doesn't the SEC require that mutual funds that own foreign dividend-paying stocks report two expense ratios"
    In order to call for the reporting of two different ERs, it was necessary for you to establish two points: that foreign taxes paid should be included in the ER reported, and that (given that taxes paid are included in the ER) that the reported amount of foreign taxes paid by the fund should be different depending on whether the owner holds the fund in a taxable or tax-deferred account.
    Stated that way, the second part sounds silly. A fund pays the same amount of dollars per share (of given share class) in expenses independent of who owns it.
    Regardless, all I needed to do to address your original question was demonstrate a problem with either of the two points (include taxes in ER, and report them two different ways). I spoke primarily to the latter, though I touched tangentially on the former.
    You cited Schwab (presumably with approval), that said the difference between a taxable account and a tax-deferred account was merely a timing issue - that in the tax deferred account "there's no deduction or credit currently available", but that nevertheless a foreign tax paid " reduces the amount of tax the IRS is able to collect when you start making withdrawals."
    I simply explained what you had cited as a reference. Suggestion for the future - if you doesn't agree with everything on a page provided as a reference, don't cite it, or say explicitly what you are citing it for. "Resource" opens the whole page up to use.
    The posts tossed in a lot of extraneous items, some of which generated more heat than light. For example, 12b-1 fees as the exemplar expense. Those fees come with a lot of baggage. You might have used almost any other fund expense instead.
    Ideally, one might try to find another fund expense that closely resembled a foreign tax. I've an idea - how about a domestic government assessment (tax or fee) paid by a fund? There's the SEC Section 31 fee that brokers tack onto your sale of securities on an exchange. (It's that little fee, typically a few cents that you see on your sell trade confirms.)
    Funds pay this government charge when they trade securities, so that's a similar expense. Oh wait, that isn't included in the ER either. Oh well :-)
    Regarding the thesis that the "only case where it would be a 'timing issue' is the one where you paid taxes at a rate of 100% on the money withdrawn from the retirement account", it's easy enough to show that isn't correct.
    We'll stay on point here and filter out as much noise as possible. We'll focus strictly comparing the impact of foreign taxes paid in a taxable account with their impact in an IRA by eliminating other sources of tax liability.
    Assume that the original contribution was nondeductible (so that there's no tax due on the principal when withdrawn). Assume that all income generated by the fund comes in the form of nonqualified dividends (so the tax rate for the taxable and IRA accounts are the same). Assume no growth of principal. We'll assume that taxes are paid from another pocket, so that this extra cash doesn't clutter calculations either.
    Getting back to my original example - in year 1, your investment earns dividends (after expenses other than foreign taxes) of $1.10. The investment pays $0.10 in foreign taxes, and distributes $1 in cash, while declaring that you have $1.10 in income. In year 2, assume no growth, no dividends. For our final assumption, we'll say that in year 2 you close out the IRA (and are over age 59.5 - no penalties).
    Remember that I'm showing only that the result in the IRA is the same as taking a deduction (not a credit) in the taxable account.
    Year 1:
    Taxable account, have an extra $1 nonqualified cash dividend in your account. You declare income of $1.10 and a deduction of $0.10, for net taxable ordinary income of $0.025 (assuming 25% tax bracket).
    IRA: You have an extra $1 in your account.
    Year 2:
    Taxable account - no change. You have the extra $1 in your taxable account, no taxes due.
    IRA: No growth. You have your original post-tax investment and $1 of increased value. You close your account. You owe ordinary income of $0.025 on that $1 (which again comes from another pocket).
    Same taxes owed. Just deferred a year. Timing.
    ---------------------------
    The conceit is that the fund is a pass through entity. It passes some of the tax liability through to you. Notably, foreign taxes, but only sometimes. When it does, it is you not the fund paying the taxes. That happens by the fund giving you the full distribution (here $1.10), and then taking back the tax amount so that it can pay it for you.
    That's not an expense of the fund (i.e. one included in the calculation of fund income passed through to you). It's your expense. As the IRS writes, "You can claim a credit only for foreign taxes that are imposed on you".
    For the IRA investor, that foreign tax is a fee like any other - a brokerage commission, a load, a redemption fee, etc. The investor gets to treat that foreign tax collected from the IRA the same way as any other expense incurred by the IRA.
    For the investor with a taxable account, the foreign tax is again an expense borne by the account, not by the fund. It is precisely because the investor (not the fund) is paying the tax that the investor gets to take a deduction or credit.
  • Transfer from one fund to other - DCA or lumpsum?
    "I plan to sell one of my funds and buy into another fund in the same category in IRA"
    "What if any would you do in this scenario?"
    ++++++++++++
    If I determine that I don't like my current fund and have found a fund I do like to replace it....then I would consider this a lateral move in the stock market and I would sell the one I don't like and go right into the one I do like. It's not an asset allocation change, just getting out of a fund you don't like and in to one you like.....so I would go with your option 1 above.
    If you sell it all into cash and then dollar cost average into the next fund [your option 3 above], you have changed your asset allocation and will be partially out of the market with that money for a period of time........so the timing of those purchases will impact your performance. If you want to be partially out of the market, that's fine....that would be a way to do it. If you feel we are heading into more market weakness and want to be partially out and dollar cost back in, that's a way to do it.
    There's no right or wrong way to do this.
    Option 2 is also fine, especially if you are concerned that the fund you sell might do better than the one you buy............anything can happen when you sell one fund and replace it with another, so option 2 can be very good.
    As you said, there are no tax implications.
    Note that in an IRA, most brokerages will not let you sell all of Fund A (say it has $25,000 in it) and buy $25,000 of Fund B on the same day. They will usually let you buy 90% of the current value of Fund A...and buy the other 10% the next day. The reason: if it is a traditional mutual fund, the price won't be known until after the market close, so the $$ amount of the proceeds won't be known.
    Cheers
  • Domestic Large Cap Value Fund - BPAVX, JVAAX, TWEIX, BRLVX?
    BPVAX remains on my short list. It seems difficult to find good actively managed LCV funds that don't drift into blend.
    Another LCV fund on my short list you might want to consider is LCEIX. Along with doing relatively well in the 2008-2009 market, they are both doing relatively well YTD (both in the top 10% in a year where only one LCV is in the black).
  • Transfer from one fund to other - DCA or lumpsum?
    I plan to sell one of my funds and buy into another fund in the same category in IRA. Please note my portfolio is balanced with proper allocations into international/domestic and value/growth categories as I need.
    My options are:
    1. Sell all shares of fundX and buy fundY in a lumpsum purchase.
    2. Sell shares of fundX in small batches of 2K or so and buy the proceeds into the new fundY like a Dollar Cost Average
    (This means at a given point of time I will have fundX in addition to fundY for a year or two before all fundX is sold)
    3. Sell all shares of fundX into cash and Dollar Cost Avg. into fundY monthly
    What if any would you do in this scenario? and do the above options matter anyway as it is in IRA and no tax benefits as such.
    Thankx
  • Domestic Large Cap Value Fund - BPAVX, JVAAX, TWEIX, BRLVX?
    I need a Large Cap Value fund for my IRA at Fidelity, preferably a NTF fund.
    I was looking at BPAVX (Boston Partners All Cap Value Fund). It did quite well **comparitively*** in down market of 2008-09. Seems like it is one of those lesser known funds but has great performance for last 10 years.
    Anyone heard of BPAVX?
    My other Options are JVAAX, TWEIX, BRLVX.
    Thoughts?